Skip to main content
xMedica

Search

46 studies match these filters. Showing 1–25 of 46 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07136012OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).

✓ Contact✗ Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 261 sites in total

RecruitingPhase 311,000target261 / 42025Nov 16, 2026
NCT07543120An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 46 sites in total · contact listed

RecruitingPhase 2323target46 / 32026Nov 16, 2026
NCT07321899Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 20 sites in total · contact listed

RecruitingNot applicable1,186target20 / 12026Nov 12, 2026
NCT07181109Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adju…

✓ Contact✗ Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 1,226 sites in total

RecruitingPhase 311,000target1,226 / 352025Nov 12, 2026
NCT06424288A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empag…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 672 sites in total · contact listed

RecruitingPhase 36,712target672 / 302024Nov 12, 2026
NCT06935370A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with chronic HF at least 3 months before they start on the study. The purpose of this study is to find out…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 596 sites in total · contact listed

RecruitingPhase 34,200target596 / 292025Nov 12, 2026
NCT07516444VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

Pivotal trial to evaluate the safety and clinical efficacy of the VDyne TriNova System for the treatment of symptomatic severe or greater tricuspid regurgitation.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 12 sites in total · contact listed

RecruitingNot applicable520target12 / 12026Nov 10, 2026
NCT07045194Virtue® SAB in the Treatment of Coronary ISR Trial

A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed

RecruitingNot applicable740target22 / 12025Oct 22, 2026
NCT06677060Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 977 sites in total

RecruitingPhase 311,300target977 / 352025Oct 21, 2026
NCT05913908EFS of the DUO System for Tricuspid Regurgitation

The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 18 sites in total · contact listed

RecruitingNot applicable15target18 / 22024Oct 21, 2026
NCT06535854Prevail Global Study

The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 79 sites in total · contact listed

RecruitingNot applicable1,205target79 / 92025Oct 21, 2026
NCT07830719Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP

The purpose of this Phase 2b study is to investigate the efficacy in reducing systemic inflammation, safety, tolerability, and dose response of five doses of YMI024, as compared to placebo in adult participants with stable coronary artery disease (CAD) and residual inflammatory risk defined by eleva…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total · contact listed

RecruitingPhase 2180target23 / 52026Oct 15, 2026
NCT06777368REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed

Recruiting225target71 / 12025Sep 24, 2026
NCT06033274Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pa…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total

Recruiting800target31 / 82023Sep 15, 2026
NCT07761117A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to investigate CV outcomes with elecoglipron compared with placebo, in adults with heart failure with preserved ejection fraction (HFpEF)/heart failure with mildly reduced ejection fraction (HFmrEF),…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 679 sites in total

RecruitingPhase 36,950target679 / 322026Sep 28, 2026
NCT05172960ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 65 sites in total

RecruitingNot applicable1,234target65 / 42022Sep 24, 2026
NCT07000357A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in patients with established ASCVD or at high risk for a first ASCVD event. The effect of AZD0780 vs pl…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 1,452 sites in total

RecruitingPhase 315,100target1,452 / 362025Aug 24, 2026
NCT05712200Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.

✓ Contact✗ Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 789 sites in total · contact listed

RecruitingPhase 32,500target789 / 352022Jul 13, 2026
NCT05378347Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follo…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 68 sites in total · contact listed

RecruitingNot applicable600target68 / 122023Jul 6, 2026
NCT05172973ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 37 sites in total

RecruitingNot applicable200target37 / 22023Oct 7, 2026
NCT06438315SuperSaturated Oxygen Comprehensive Observational Registry

The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility, infarct size reduction, and cost-effectiveness of SSO2 Therapy versus PCI alone among patients with anterior AMI in routine clinical practice.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 27 sites in total · contact listed

Recruiting1,000target27 / 12024Nov 2, 2026
NCT06779630Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) \>36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total

RecruitingNot applicable150target23 / 62025Nov 5, 2026
NCT07090161Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 28 sites in total

RecruitingPhase 2240target28 / 12025Feb 27, 2026
NCT05061004Cephea Early Feasibility Study

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed

RecruitingNot applicable90target22 / 22022Sep 11, 2026
NCT04889872PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 80 sites in total

RecruitingNot applicable2,250target80 / 62021Dec 17, 2025

Filters

Clear all filters